CombiMatrix Corporation (CBMX)
-NasdaqCM 2.95 
0.41(16.14%) 4:00PM EDT
| Prev Close: | 2.54 |
|---|
| Open: | 2.85 |
|---|
| Bid: | 2.86 x 3000 |
|---|
| Ask: | 2.97 x 1700 |
|---|
| 1y Target Est: | 15.00 |
|---|
| Beta: | 0.13 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2.83 - 3.19 |
|---|
| 52wk Range: | 1.40 - 14.14 |
|---|
| Volume: | 1,533,408 |
|---|
| Avg Vol (3m): | 362,320 |
|---|
| Market Cap: | 10.58M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -6.15 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- InPlay: CombiMatrix: Six Months After Publication of Key Studies, CombiMatrix Sees Growth in Prenatal Testing AdoptionBriefing.com(Tue 6:04AM EDT)
- Six Months After Publication of Key Studies, CombiMatrix Sees Growth in Prenatal Testing AdoptionGlobeNewswire(Tue 6:00AM EDT)
- COMBIMATRIX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online(Mon, Jun 17)
- COMBIMATRIX CORP Files SEC form 8-K, Other EventsEDGAR Online(Thu, May 30)
- COMBIMATRIX CORP FinancialsEDGAR Online Financials(Tue, May 21)
- COMBIMATRIX CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 13)
- CombiMatrix Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 8)
- Q1 2013 Combimatrix Earnings Release - Before Market OpenCCBN(Wed, May 8)
- CombiMatrix Corporation Reports Results for 2013 First QuarterGlobeNewswire(Wed, May 8)
- COMBIMATRIX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Tue, May 7)
- CombiMatrix Executes Equity FinancingGlobeNewswire(Mon, May 6)
- COMBIMATRIX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SecuritiEDGAR Online(Sun, May 5)
- COMBIMATRIX CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Fri, May 3)
- CombiMatrix Corporation to Release First Quarter Financial Results on May 8, 2013GlobeNewswire(Wed, May 1)
- 5 Health Care Stocks Under $10 Ready to Rip Higherat TheStreet(Thu, Apr 18)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.60 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-10)
: | N/A |
|---|
| Quarterly EPS Est
(Dec-10)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
CombiMatrix Corporation, a molecular diagnostics company, operates primarily in the field of genetic analysis and molecular diagnostics. The company, through its subsidiary, CombiMatrix Molecular Diagnostics, Inc., operates a diagnostics reference...
View More